Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q2 2025 Earnings Call Transcript August 4, 2025
Syndax Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.83, expectations were $-1.
Operator: Good day, everyone, and welcome to the Syndax Second Quarter 2025 Earnings Conference Call. Today’s call is being recorded. [Operator Instructions] At this time, I would like to turn the call over to Sharon Klahre, Head of Investor Relations at Syndax Pharmaceuticals. Sharon Klahre Thank...
